CCNG2 Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Selected Variant
bs-3822R-BF555-TR
Size: 20 µL
Product Specifications
Background
Cyclin G2 may play a role in growth regulation and in negative regulation of cell cycle progesssion. Cyclin G2 expression levels increase through the cell cycle to peak in the mid/late-S phase and decrease during G2/M phase. It may also contribute in maintaining the quiescent state of differentiated cells. Cyclin G2 is similar to cyclin A in the cyclin box, although no kinase activity is detected.
Synonyms
Cyclin-G2; CCNG2
Gene ID
901
Swiss Prot
Q16589
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Rat
Immunogen
151-250/344
Target
CCNG2
Clonality
Polyclonal
Conjugation
AbBy Fluor™ 555
Source
KLH conjugated synthetic peptide derived from human Cyclin G2
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
553nm/568nm
Concentration
1ug/ul
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Prediction Reactivity
Mouse, Dog, Cow, Pig, Horse
Gene ID URL
901
Isotype
IgG
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A30759-1-Dylight550 100 µg
Anti-SEPT7/SEPTIN7 Antibody Picoband®, Dylight550 Conjugate
Sign In for Pricing
View Details ![DM1 Mouse Monoclonal Antibody [A4G2]](https://cdn.genprice.uk/products/992/68dd1c8a061270361ea81041/imageurl/ha600013.webp)
A01312-1-Dylight488 100 µg
Anti-SATB1 Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details 
BNC740461-100 1x 100 µL
Chromogranin A (PHE5), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB2105-100 1x 100 µL
Myoglobin (Muscle Cell Marker) (MB/2105), 0.2mg/mL
Sign In for Pricing
View Details 